The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer

Speaking of SurgOnc - A podcast by Annals of Surgical Oncology and Society of Surgical Oncology - Tuesdays

Rick Green, MD and Dr. Anna Weiss, MD discuss clinical trials that have defined the role of neoadjuvant endocrine therapy in patients with estrogen receptor-positive breast cancer. Dr. Weiss is author of “The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.” Dr. Weiss is Assistant Professor of Surgery at Harvard Medical School, Boston, MA.